Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study

BACKGROUND: In spite of laser being the gold standard treatment for Diabetic Macular edema (DME), some patients do not respond to laser. Various treatment modalities are being tried in the management of refractory diffuse DME (DDME). PURPOSE: To compare the efficacy of intravitreal bevacizumab (IVB)...

Descripción completa

Detalles Bibliográficos
Autores principales: Azad, Rajvardhan, Sain, Siddarth, Sharma, Yog Raj, Mahajan, Deepankur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574512/
https://www.ncbi.nlm.nih.gov/pubmed/23439853
http://dx.doi.org/10.4103/0974-620X.106100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574512/
https://www.ncbi.nlm.nih.gov/pubmed/23439853
http://dx.doi.org/10.4103/0974-620X.106100

Ejemplares similares